0001387131-18-004753.txt : 20180914 0001387131-18-004753.hdr.sgml : 20180914 20180914193457 ACCESSION NUMBER: 0001387131-18-004753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180912 FILED AS OF DATE: 20180914 DATE AS OF CHANGE: 20180914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bernick Brian CENTRAL INDEX KEY: 0001532233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 181072191 MAIL ADDRESS: STREET 1: 951 BROKEN SOUND PARKWAY NW STREET 2: SUITE 320 CITY: BOCA RATON STATE: FL ZIP: 33487 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 561-961-1911 MAIL ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4 1 bernick-form4_091218.xml OWNERSHIP DOCUMENT X0306 4 2018-09-12 0 0000025743 TherapeuticsMD, Inc. TXMD 0001532233 Bernick Brian 6800 BROKEN SOUND PKWY NW, THIRD FLOOR BOCA RATON FL 33487 1 0 0 0 Common Stock 2018-09-12 4 M 0 91400 0.1018 A 6648771 I By BF Investment Enterprises, Ltd. Common Stock 2018-09-12 4 S 0 91400 6.255 D 6557371 I By BF Investment Enterprises, Ltd. Common Stock 2018-09-13 4 M 0 91400 0.1018 A 6648771 I By BF Investment Enterprises, Ltd. Common Stock 2018-09-13 4 S 0 91400 6.345 D 6557371 I By BF Investment Enterprises, Ltd. Common Stock 242000 D Common Stock 3000 I By BF Management, LLC Non-Qualified Stock Option (right to buy) 0.1018 2018-09-12 4 M 0 91400 0 D 2012-01-01 2019-01-01 Common Stock 91400 1371510 I By BF Investment Enterprises, Ltd. Non-Qualified Stock Option (right to buy) 0.1018 2018-09-13 4 M 0 91400 0 D 2012-01-01 2019-01-01 Common Stock 91400 1280110 I By BF Investment Enterprises, Ltd. The reported securities are owned by BF Investment Enterprises, Ltd. ("BF Investment"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the "GP"), the general partner of BF Investment, (ii) holds, together with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.34, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported securities are held by the GP. As disclosed in footnote 1 above, the Reporting Person, together with his spouse as tenants by the entirety, holds a 70.6% membership interest in the GP. The Reporting Person disclaims beneficial ownership of the reported securities held by the GP, except to the extent of his pecuniary interest therein. /s/ Brian Bernick 2018-09-14